Autopsy report · NCT02115256

Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline

“difficult recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 9 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 2 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Yaakov Beilin

Sponsor type

University, hospital or other

Conditions

External Cephalic Version

Interventions

Intravenous Terbutaline; Intravenous Nitroglycerine

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis
  “Difficulty in recruitment” (94% match in meaning)
• Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
  “Difficulty with recruitment.” (94% match in meaning)
• Alzheimer Disease : Rehabilitation's Intervention at Home
  “difficulties of recruitment” (94% match in meaning)
• A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study
  “Difficulty of recruitment.” (94% match in meaning)
• Improving Access to Psychiatric Care for Patients in Primary Care
  “recruitment difficulties” (94% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.